Results
1 -
10 of
73Matthew Habgood, Ricardo Grau-Crespo and Sarah L. Price.
Substitutional and orientational disorder in organic crystals: a symmetry-adapted ensemble model, Phys. Chem. Chem. Phys., 2011, 13, 9590. Hattori Kazuo, Kohchi Yasunori, Oikawa Nobuhiro, Suda Hitomi, Ura Masako, Ishikawa Tohru, Miwa Masanori, Endoh Mika, Eda Hiroyuki, Tanimura Hiromi, Kawashima Akira, Horii Ikuo, Ishitsuka Hideo, Shimma Nobuo.
Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine, Bioorganic & Medicinal Chemistry Letters, 2003 A phase II study of S-1 in patients with metastatic breast cancer u2014 A Japanese trial by the S-1 cooperative study group, breast cancer working group, Breast Cancer Recent insights into the molecular basis of intrinsic resistance of colorectal cancer: new challenges for systemic therapeutic approaches, Gastrointestinal Oncology 5-Fluorouracil and dihydropyrimidine dehydrogenase, International Journal of Clinical Oncology Corneal Lesions in Beagle Dogs Given Oral 5-Ethynyluracil Followed by 5-Fluorouracil, Advances in Ocular Toxicology Estimation of the effect of food on the disposition of oral 5-fluorouracil in combination with eniluracil, Cancer Chemotherapy and Pharmacology Dihydropyrimidine Dehydrogenase in Livers from Mouse and Rat, and in Human Liver, Colon Tumors, and Mucosa in Relation to Anabolism of 5-Fluorouracil, Purine and Pyrimidine Metabolism in Man IX High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1, Cancer Chemotherapy and Pharmacology Dihydropyrimidine dehydrogenase (DPD) rapidly regenerates after inactivation by eniluracil (GW776C85) in primary and metastatic colorectal cancer, Cancer Chemotherapy and Pharmacology